Literature DB >> 21774840

Enriched cereal bars are more effective in increasing plasma quercetin compared with quercetin from powder-filled hard capsules.

Sarah Egert1, Siegfried Wolffram, Beate Schulze, Peter Langguth, Eva Maria Hubbermann, Karin Schwarz, Berit Adolphi, Anja Bosy-Westphal, Gerald Rimbach, Manfred James Müller.   

Abstract

The flavonol quercetin, is one of the major flavonoids found in edible plants. The bioavailability of quercetin in humans may be influenced by the food matrix in which it is consumed as well as by its chemical and physical form. The objective of the present study was to investigate the biokinetics of quercetin from quercetin-enriched cereal bars and quercetin powder-filled hard capsules. In a randomised, single-blinded, diet-controlled cross-over study, six healthy women aged 22-28 years took a single oral dose of approximately 130 mg quercetin equivalents from either quercetin-enriched cereal bars (containing 93·3 % quercetin aglycone plus 6·7 % quercetin-4'-glucoside) or quercetin powder-filled hard capsules (100 % quercetin aglycone). Blood samples were drawn before and after quercetin administration over a 24 h period. The concentrations of quercetin and its monomethylated derivatives, isorhamnetin (3'-O-methyl quercetin) and tamarixetin (4'-O-methyl quercetin), were measured by HPLC with fluorescence detection after plasma enzymatic treatment. The systemic availability as determined by comparing the plasma concentration-time curves of quercetin was found to be five times and the cmax values six times higher after ingestion of 130 mg quercetin by quercetin-enriched cereal bars than after ingestion by quercetin capsules. In contrast, tmax did not differ significantly between the two treatments. The cmax values for isorhamnetin and tamarixetin were four and nine times higher after ingestion of quercetin by quercetin-enriched cereal bars than after ingestion by quercetin capsules. In conclusion, quercetin from quercetin-enriched cereal bars is significantly more bioavailable than from quercetin powder-filled hard capsules.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21774840     DOI: 10.1017/S0007114511003242

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  12 in total

1.  Higher plasma quercetin levels following oral administration of an onion skin extract compared with pure quercetin dihydrate in humans.

Authors:  Constanze Burak; Verena Brüll; Peter Langguth; Benno F Zimmermann; Birgit Stoffel-Wagner; Udo Sausen; Peter Stehle; Siegfried Wolffram; Sarah Egert
Journal:  Eur J Nutr       Date:  2015-10-20       Impact factor: 5.614

2.  No effects of quercetin from onion skin extract on serum leptin and adiponectin concentrations in overweight-to-obese patients with (pre-)hypertension: a randomized double-blinded, placebo-controlled crossover trial.

Authors:  Verena Brüll; Constanze Burak; Birgit Stoffel-Wagner; Siegfried Wolffram; Georg Nickenig; Cornelius Müller; Peter Langguth; Birgit Alteheld; Rolf Fimmers; Peter Stehle; Sarah Egert
Journal:  Eur J Nutr       Date:  2016-07-16       Impact factor: 5.614

3.  Effects of a high fat meal matrix and protein complexation on the bioaccessibility of blueberry anthocyanins using the TNO gastrointestinal model (TIM-1).

Authors:  David M Ribnicky; Diana E Roopchand; Andrew Oren; Mary Grace; Alexander Poulev; Mary Ann Lila; Robert Havenaar; Ilya Raskin
Journal:  Food Chem       Date:  2013-07-25       Impact factor: 7.514

4.  Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model.

Authors:  Tongyu Cao Wikramanayake; Alexandra C Villasante; Lucia M Mauro; Carmen I Perez; Lawrence A Schachner; Joaquin J Jimenez
Journal:  Cell Stress Chaperones       Date:  2011-11-01       Impact factor: 3.667

5.  Estimated daily quercetin intake and association with the prevalence of type 2 diabetes mellitus in Chinese adults.

Authors:  Zhanxin Yao; Yeqing Gu; Qing Zhang; Li Liu; Ge Meng; Hongmei Wu; Yang Xia; Xue Bao; Hongbin Shi; Shaomei Sun; Xing Wang; Ming Zhou; Qiyu Jia; Yuntang Wu; Kun Song; Weina Gao; Changjiang Guo; Kaijun Niu
Journal:  Eur J Nutr       Date:  2018-05-12       Impact factor: 5.614

Review 6.  Understanding the gastrointestinal tract of the elderly to develop dietary solutions that prevent malnutrition.

Authors:  Didier Rémond; Danit R Shahar; Doreen Gille; Paula Pinto; Josefa Kachal; Marie-Agnès Peyron; Claudia Nunes Dos Santos; Barbara Walther; Alessandra Bordoni; Didier Dupont; Lidia Tomás-Cobos; Guy Vergères
Journal:  Oncotarget       Date:  2015-06-10

7.  Orange juice-derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease.

Authors:  Manuel Y Schär; Peter J Curtis; Sara Hazim; Luisa M Ostertag; Colin D Kay; John F Potter; Aedín Cassidy
Journal:  Am J Clin Nutr       Date:  2015-03-18       Impact factor: 7.045

Review 8.  A comprehensive review on beneficial dietary phytochemicals in common traditional Southern African leafy vegetables.

Authors:  Dharini Sivakumar; Lingyun Chen; Yasmina Sultanbawa
Journal:  Food Sci Nutr       Date:  2018-04-14       Impact factor: 2.863

9.  Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial.

Authors:  Verena Brüll; Constanze Burak; Birgit Stoffel-Wagner; Siegfried Wolffram; Georg Nickenig; Cornelius Müller; Peter Langguth; Birgit Alteheld; Rolf Fimmers; Stefanie Naaf; Benno F Zimmermann; Peter Stehle; Sarah Egert
Journal:  Br J Nutr       Date:  2015-09-02       Impact factor: 3.718

Review 10.  Flavonoid bioavailability and attempts for bioavailability enhancement.

Authors:  Surangi H Thilakarathna; H P Vasantha Rupasinghe
Journal:  Nutrients       Date:  2013-08-28       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.